EMA — authorised 11 January 2008
- Marketing authorisation holder: GlaxoSmithKline (Ireland) Limited
- Status: approved
🇪🇺 Arnuity Ellipta in European Union
EMA authorised Arnuity Ellipta on 11 January 2008
Marketing authorisation
Arnuity Ellipta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in European Union
Frequently asked questions
Is Arnuity Ellipta approved in European Union?
Yes. EMA authorised it on 11 January 2008.
Who is the marketing authorisation holder for Arnuity Ellipta in European Union?
GlaxoSmithKline (Ireland) Limited holds the EU marketing authorisation.